These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Use of high-content analysis for compound screening and target selection. Rausch O IDrugs; 2005 Jul; 8(7):573-7. PubMed ID: 15973566 [TBL] [Abstract][Full Text] [Related]
5. High-content screening moves to the front of the line. Haney SA; LaPan P; Pan J; Zhang J Drug Discov Today; 2006 Oct; 11(19-20):889-94. PubMed ID: 16997138 [TBL] [Abstract][Full Text] [Related]
7. High-throughput screening: update on practices and success. Fox S; Farr-Jones S; Sopchak L; Boggs A; Nicely HW; Khoury R; Biros M J Biomol Screen; 2006 Oct; 11(7):864-9. PubMed ID: 16973922 [TBL] [Abstract][Full Text] [Related]
8. Smart screening: approaches to efficient HTS. Engels MF; Venkatarangan P Curr Opin Drug Discov Devel; 2001 May; 4(3):275-83. PubMed ID: 11560058 [TBL] [Abstract][Full Text] [Related]
9. Exploring the chemogenomic knowledge space with annotated chemical libraries. Savchuk NP; Balakin KV; Tkachenko SE Curr Opin Chem Biol; 2004 Aug; 8(4):412-7. PubMed ID: 15288252 [TBL] [Abstract][Full Text] [Related]
10. A personal perspective on high-content screening (HCS): from the beginning. Taylor DL J Biomol Screen; 2010 Aug; 15(7):720-5. PubMed ID: 20639498 [TBL] [Abstract][Full Text] [Related]
11. A multiplexed approach to hit finding. Slack M; Winkler D; Krämer J; Hesterkamp T Curr Opin Drug Discov Devel; 2009 May; 12(3):351-7. PubMed ID: 19396736 [TBL] [Abstract][Full Text] [Related]
12. Natural products in drug discovery. Harvey AL Drug Discov Today; 2008 Oct; 13(19-20):894-901. PubMed ID: 18691670 [TBL] [Abstract][Full Text] [Related]
13. In silico toxicology for the pharmaceutical sciences. Valerio LG Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836 [TBL] [Abstract][Full Text] [Related]
14. Potential of label-free detection in high-content-screening applications. Proll G; Steinle L; Pröll F; Kumpf M; Moehrle B; Mehlmann M; Gauglitz G J Chromatogr A; 2007 Aug; 1161(1-2):2-8. PubMed ID: 17612548 [TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical industry screening for new antiepileptic drugs. Taylor CP; Marks JL Adv Neurol; 1998; 76():41-7. PubMed ID: 9408462 [TBL] [Abstract][Full Text] [Related]
16. Enabling high-throughput discovery. Vaschetto M; Weissbrod T; Bodle D; Güner O Curr Opin Drug Discov Devel; 2003 May; 6(3):377-83. PubMed ID: 12833671 [TBL] [Abstract][Full Text] [Related]
18. [The role of high throughput screening in the early stage of drug research]. Keserü GM Acta Pharm Hung; 2004; 74(1):5-10. PubMed ID: 15524043 [TBL] [Abstract][Full Text] [Related]
19. High-content assays in oncology drug discovery: opportunities and challenges. Mouchet EH; Simpson PB IDrugs; 2008 Jun; 11(6):422-7. PubMed ID: 18509783 [TBL] [Abstract][Full Text] [Related]